Erratum: Hypoxia inducible factor 3α plays a critical role in alveolarization and distal epithelial cell differentiation during mouse lung development (The PLOS ONE Staff (2013) 8:2 (e57695) DOI: 10.1371/journal.pone.0057695);Hypoxia Inducible Factor 3α Plays a Critical Role in Alveolarization and Distal Epithelial Cell Differentiation during Mouse Lung Development

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Huang, Yadi ^a   Kapere Ochieng, Joshua ^a   Kempen, Marjon Buscop van ^a   Munck, Anne Boerema de ^a   Swagemakers, Sigrid ^b   van IJcken, Wilfred ^b   Grosveld, Frank ^b   Tibboel, Dick ^a   Rottier, Robbert J ^a,b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLARA CELL PROTEIN; DNA; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 3ALPHA; PROTEIN P63; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR FOXP2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CCSP GENE; CELL COUNT; CELL DIFFERENTIATION; CLARA CELL; CONTROLLED STUDY; DNA STRUCTURE; EMBRYO; FOXP2 GENE; GESTATION PERIOD; HUMAN; HUMAN CELL; HYPOXIA RESPONSIVE ELEMENT; LUNG ALVEOLUS; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; LUNG MALFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; P63 GENE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RARBETA GENE; REGULATOR GENE; REPORTER GENE; SOX2 GENE; TRANSACTIVATION; TRANSGENIC MOUSE;

EID: 84874367417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119359     Document Type: Erratum

References (95)

1. Maeda Y, Dave V, Whitsett JA, (2007) Transcriptional control of lung morphogenesis. Physiol Rev 87: 219-244.
2. Morrisey EE, Hogan BL, (2010) Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell 18: 8-23.
3. Rawlins EL (2010) The building blocks of mammalian lung development. Dev Dyn.
4. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, et al. (2001) Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 220: 175-186.
5. van Tuyl M, Liu J, Wang J, Kuliszewski M, Tibboel D, et al. (2005) Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 288: L167-178.
6. Dunwoodie SL, (2009) The role of hypoxia in development of the Mammalian embryo. Dev Cell 17: 755-773.
7. Rajatapiti P, van der Horst IW, de Rooij JD, Tran MG, Maxwell PH, et al. (2008) Expression of hypoxia-inducible factors in normal human lung development. Pediatr Dev Pathol 11: 193-199.
8. Greer SN, Metcalf JL, Wang Y, Ohh M, (2012) The updated biology of hypoxia-inducible factor. EMBO J 31: 2448-2460.
9. Semenza GL, (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
10. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL, (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778.
11. Wang GL, Jiang BH, Rue EA, Semenza GL, (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510-5514.
12. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, et al. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537.
13. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, et al. (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 94: 4273-4278.
14. Flamme I, Frohlich T, von Reutern M, Kappel A, Damert A, et al. (1997) HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels. Mech Dev 63: 51-60.
15. Tian H, McKnight SL, Russell DW, (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11: 72-82.
16. Hara S, Hamada J, Kobayashi C, Kondo Y, Imura N, (2001) Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun 287: 808-813.
17. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Qadri F, et al. (2003) Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J 17: 1541-1543.
18. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, et al. (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414: 550-554.
19. Makino Y, Kanopka A, Wilson WJ, Tanaka H, Poellinger L, (2002) Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem 277: 32405-32408.
20. Maynard MA, Qi H, Chung J, Lee EH, Kondo Y, et al. (2003) Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J Biol Chem 278: 11032-11040.
21. Bruick RK, McKnight SL, (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340.
22. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54.
23. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464-468.
24. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472.
25. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ, (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 20: 5197-5206.
26. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA, (1998) Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 7: 205-213.
27. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, et al. (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279: 38458-38465.
28. Huang LE, Gu J, Schau M, Bunn HF, (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95: 7987-7992.
29. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, et al. (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275: 25733-25741.
30. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, et al. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2: 423-427.
31. Tanimoto K, Makino Y, Pereira T, Poellinger L, (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19: 4298-4309.
32. Salceda S, Caro J, (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272: 22642-22647.
33. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
34. Kaelin WG Jr, Ratcliffe PJ, (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30: 393-402.
35. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, et al. (2009) Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 284: 16767-16775.
36. Schodel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, et al. (2011) High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117: e207-217.
37. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, et al. (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16: 1466-1471.
38. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML, (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861.
39. Mahon PC, Hirota K, Semenza GL, (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686.
40. Lisy K, Peet DJ, (2008) Turn me on: regulating HIF transcriptional activity. Cell Death Differ 15: 642-649.
41. Webb JD, Coleman ML, Pugh CW, (2009) Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol Life Sci 66: 3539-3554.
42. Yamashita T, Ohneda O, Nagano M, Iemitsu M, Makino Y, et al. (2008) Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS. Mol Cell Biol 28: 1285-1297.
43. Maynard MA, Evans AJ, Hosomi T, Hara S, Jewett MA, et al. (2005) Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J 19: 1396-1406.
44. Makino Y, Uenishi R, Okamoto K, Isoe T, Hosono O, et al. (2007) Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J Biol Chem 282: 14073-14082.
45. Li QF, Wang XR, Yang YW, Lin H, (2006) Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell Res 16: 548-558.
46. Yoshida T, Kuwahara M, Maita K, Harada T, (2001) Immunohistochemical study on hypoxia in spontaneous polycystic liver and kidney disease in rats. Exp Toxicol Pathol 53: 123-128.
47. Augstein A, Poitz DM, Braun-Dullaeus RC, Strasser RH, Schmeisser A, (2011) Cell-specific and hypoxia-dependent regulation of human HIF-3alpha: inhibition of the expression of HIF target genes in vascular cells. Cell Mol Life Sci 68: 2627-2642.
48. Keith B, Adelman DM, Simon MC, (2001) Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc Natl Acad Sci U S A 98: 6692-6697.
49. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC, (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386: 403-407.
50. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, et al. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12: 149-162.
51. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, et al. (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710.
52. Peng J, Zhang L, Drysdale L, Fong GH, (2000) The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 97: 8386-8391.
53. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, et al. (2003) Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 35: 331-340.
54. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL, (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12: 3320-3324.
55. Huang Y, Kempen MB, Munck AB, Swagemakers S, Driegen S, et al. (2012) Hypoxia-inducible factor 2alpha plays a critical role in the formation of alveoli and surfactant. Am J Respir Cell Mol Biol 46: 224-232.
56. Tanaka T, Wiesener M, Bernhardt W, Eckardt KU, Warnecke C, (2009) The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction. Biochem J 424: 143-151.
57. Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, et al. (2008) Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol 317: 296-309.
58. Raghoebir L, Bakker ER, Mills JC, Swagemakers S, Buscop-van Kempen M, et al. (2012) SOX2 redirects the developmental fate of the intestinal epithelium toward a premature gastric phenotype. J Mol Cell Biol.
59. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, et al. (2005) Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 390: 189-197.
60. Perl AK, Tichelaar JW, Whitsett JA, (2002) Conditional gene expression in the respiratory epithelium of the mouse. Transgenic Res 11: 21-29.
61. Zhang F, Pan T, Nielsen LD, Mason RJ, (2004) Lipogenesis in fetal rat lung: importance of C/EBPalpha, SREBP-1c, and stearoyl-CoA desaturase. Am J Respir Cell Mol Biol 30: 174-183.
62. Hirche TO, Crouch EC, Espinola M, Brokelman TJ, Mecham RP, et al. (2004) Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J Biol Chem 279: 27688-27698.
63. Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, et al. (2007) Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 55: 71-83.
64. Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D, et al. (2007) Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 134: 1991-2000.
65. Shu W, Yang H, Zhang L, Lu MM, Morrisey EE, (2001) Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J Biol Chem 276: 27488-27497.
66. Malpel S, Mendelsohn C, Cardoso WV, (2000) Regulation of retinoic acid signaling during lung morphogenesis. Development 127: 3057-3067.
67. Wongtrakool C, Malpel S, Gorenstein J, Sedita J, Ramirez MI, et al. (2003) Down-regulation of retinoic acid receptor alpha signaling is required for sacculation and type I cell formation in the developing lung. J Biol Chem 278: 46911-46918.
68. Moreno-Manzano V, Rodriguez-Jimenez FJ, Acena-Bonilla JL, Fustero-Lardies S, Erceg S, et al. (2010) FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status. J Biol Chem 285: 1333-1342.
69. Iyer NV, Leung SW, Semenza GL, (1998) The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 52: 159-165.
70. Kotch LE, Iyer NV, Laughner E, Semenza GL, (1999) Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209: 254-267.
71. Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, et al. (2003) Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res 60: 569-579.
72. Shimoda LA, Semenza GL, (2011) HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med 183: 152-156.
73. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, et al. (2010) Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A 107: 11459-11464.
74. Simonson TS, Yang Y, Huff CD, Yun H, Qin G, et al. (2010) Genetic evidence for high-altitude adaptation in Tibet. Science 329: 72-75.
75. Xu S, Li S, Yang Y, Tan J, Lou H, et al. (2011) A genome-wide search for signals of high-altitude adaptation in Tibetans. Mol Biol Evol 28: 1003-1011.
76. Yi X, Liang Y, Huerta-Sanchez E, Jin X, Cuo ZX, et al. (2010) Sequencing of 50 human exomes reveals adaptation to high altitude. Science 329: 75-78.
77. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, et al. (2003) Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 111: 1519-1527.
78. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, et al. (1999) Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 103: 691-696.
79. Bridges JP, Lin S, Ikegami M, Shannon JM, (2012) Conditional hypoxia inducible factor-1alpha induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesis. Dev Biol 362: 24-41.
80. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL, (2003) Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63: 6130-6134.
81. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC, (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23: 9361-9374.
82. Wang V, Davis DA, Haque M, Huang LE, Yarchoan R, (2005) Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65: 3299-3306.
83. Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC, (2006) Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66: 5641-5647.
84. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, et al. (2006) Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281: 15215-15226.
85. Warnecke C, Weidemann A, Volke M, Schietke R, Wu X, et al. (2008) The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp Cell Res 314: 2016-2027.
86. Torii S, Goto Y, Ishizawa T, Hoshi H, Goryo K, et al. (2011) Pro-apoptotic activity of inhibitory PAS domain protein (IPAS), a negative regulator of HIF-1, through binding to pro-survival Bcl-2 family proteins. Cell Death Differ 18: 1711-1725.
87. Brahimi-Horn MC, Bellot G, Pouyssegur J, (2011) Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev 21: 67-72.
88. Pouyssegur J, Dayan F, Mazure NM, (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443.
89. Forristal CE, Wright KL, Hanley NA, Oreffo RO, Houghton FD, (2010) Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 139: 85-97.
90. Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, et al. (2011) HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71: 4640-4652.
91. Massaro GD, Massaro D, Chan WY, Clerch LB, Ghyselinck N, et al. (2000) Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol Genomics 4: 51-57.
92. Zhou B, Zhong Q, Minoo P, Li C, Ann DK, et al. (2008) Foxp2 inhibits Nkx2.1-mediated transcription of SP-C via interactions with the Nkx2.1 homeodomain. Am J Respir Cell Mol Biol 38: 750-758.
93. Londhe VA, Maisonet TM, Lopez B, Jeng JM, Li C, et al. (2011) A subset of epithelial cells with CCSP promoter activity participates in alveolar development. Am J Respir Cell Mol Biol 44: 804-812.
94. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, et al. (2004) Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 18: 1462-1464.
95. Loboda A, Jozkowicz A, Dulak J, (2012) HIF-1 versus HIF-2--is one more important than the other? Vascul Pharmacol 56: 245-251.